Wednesday, December 22, 2004

Therapy? Or Pills? A Quandary in Britain
New York Times story - "One year after British drug regulators advised against prescribing a new generation of antidepressants, except Prozac, for depressed adolescents, British doctors say they are in a frustrating bind. Warned away from using the antidepressants, they are recommending psychotherapy for their young patients instead. But under the British health system, depressed teenagers face a six- to nine-month waiting list for psychotherapy, a situation unlikely to improve in the short term..."  
  

Rx: Read This
Washington Post story - "Most people wouldn't consider a major purchase without first comparing price and reliability of the products in question. But that task has been next to impossible for consumers of prescription drugs. This has been particularly painful for the 45 million Americans who are uninsured at some point during the year and the 25 million who are insured but have modest or no drug coverage. But now the standard bearer of comparison shopping -- Consumer Reports, published by the nonprofit Consumers Union -- has launched a free service that reports on the safety, effectiveness and cost of drugs. In each category of medication, Consumer Reports even flags "best buys" -- the drugs it considers to offer the safest and most effective therapy for the money." "wp" See also the web site Best Buy Drugs.  
  

Giving them a sick feeling
LA Times story - "America's pharmaceutical industry is putting out an advisory about the latest potential threat to its health: Michael Moore. Moore, the filmmaker whose targets have included General Motors ("Roger & Me"), the gun lobby (the Oscar-winning "Bowling for Columbine") and President Bush ("Fahrenheit 9/11") has now set his sights on the healthcare industry, including insurance companies, HMOs, the Food and Drug Administration — and drug companies. At least six of the nation's largest firms have already issued internal notices to their workforces, preparing them for potential ambushes..." [Viewing Los Angeles Times stories requires registration, which is free].